Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
10 quarters on record

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Derivatives in CADL

reported options exposure · as of Jun 30, 2026
CallValue
$1,561,480
CallShares
151,600
PutValue
$245,140
PutShares
23,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in CADL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $245,140 23,800
2026-06-30 $1,561,480 151,600
2026-03-31 $742,350 151,500
2025-12-31 $748,060 132,400
2025-12-31 $61,013 10,799
2025-09-30 $563,040 110,400
2025-06-30 $740,278 146,300
2025-03-31 $316,965 56,100
2025-03-31 $191,535 33,900
2024-12-31 $262,136 30,200
2024-12-31 $143,844 16,572
2024-09-30 $227,261 32,794
2024-09-30 $277,200 40,000
2024-06-30 $74,152 11,960
2022-12-31 $24,030 13,425